Prophase Diagnostics News Today

ProPhase Labs, Inc. (NASDAQ: PRPH) fell Tuesday, as the company, a next generation biotech, genomics, therapeutics and diagnostics company, today reported that Jason Karkus, one of the driving forces behind ProPhase Diagnostics, becomes President of ...

Operator: Good day, and welcome to the ProPhase Labs Second Quarter 2023 Financial Results and Corporate Update. All participants’ will be in a listen-only mode.

Garden City, NY, April 28, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a next-generation biotech, genomics and diagnostics...

GARDEN CITY, NY, Jan. 05, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a growth oriented and diversified diagnostics,...

Operator: Good morning, afternoon, evening, and welcome to the ProPhase Labs Third Quarter 2022 Financial Results Conference Call. All participants will be in listen-only mode.

Investegate announcements from Darktrace PLC, Darktrace Sees Strong Demand for PREVENT Products

New data commissioned by Darktrace shows almost two-thirds of organizations do not have high confidence in identifying their greatest vulnerabilities81% believe AI technology would help them

Nebula Genomics Strengthens Advisory Board with Appointment of Russ Altman, M.D., Ph.D. - read this article along with other careers information, tips and advice on BioSpace

GARDEN CITY, NY, Oct. 17, 2022 -- ProPhase Labs, Inc. , a growth-oriented and diversified diagnostics, genomics and biotech company, today announced that its wholly owned subsidiary, Nebula... | October 17, 2022

GARDEN CITY, NY, Sept. 06, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and...